Table 2.
Plasma concentration of amino acids in different groups of pregnant women
| Amino acids (μUI/L) | GDM (n = 31) | T2D (n = 27) | NG (n = 25) | P-value |
|---|---|---|---|---|
| ASN | 35.37 (28.23–40.53) | 39 (22.09–53.69) | 25.48 (19.70–31.81) | 0.01 |
| SER | 67.54 (52.13–95.75) | 65.44 (41.37–94.41) | 72.85 (54.93–87.09) | 0.60 |
| HIS | 39.57 (27.57–67.69) | 33.88 (23.23–56.9) | 45.78 (22.13–80.71) | 0.39 |
| ARG | 61.50 (38.72–84.34) | 34.45 (25.47–64.13) | 41 (30.11–65.39) | 0.01 |
| CIT | 20.62 (15.16–29.6) | 23.02 (13.80–34.09) | 16.69 (13.09–22.74) | 0.26 |
| GLY | 135.48 (79.77–162.88) | 44.04 (20.48–146.37) | 105.51 (82.73–139.19) | 0.01 |
| THR | 128.8 (86.79–206.44) | 100 (64.56–197.83) | 88.39 (69.38–133) | 0.08 |
| TYR | 39.28 (30.70–46.64) | 49.24 (40.1–66.6) | 35.87 (25.58–42.13) | <0.01 |
| MET | 24.42 (17.56–29.01) | 18.9 (14.19–25.45) | 20.02 (14.59–23.07) | 0.04 |
| VAL | 166.54 (129.21–210.76) | 270.69 (215.06–366.65) | 135.30 (110.36–175.52) | <0.01 |
| PHE | 49.74 (32.91–54.61) | 54.26 (45.06–67.35) | 42 (28.99–48.78) | <0.01 |
| LEU | 95.02 (67.14–1130.50) | 104.38 (72.17–148.20) | 73.52 (62.93–107.91) | 0.07 |
| ORN | 21.55 (15.98–32.73) | 19.51 (10.08–33.87) | 19.7 (13.01–38.47) | 0.50 |
| ASP | 11.01 (9.54–15.15) | 10.22 (6.36–13.01) | 9.16 (6.24–12.21) | 0.05 |
| GLU | 98.60 (75.72–152.132) | 124 (83.92–174) | 71.41 (48.13–114) | <0.01 |
| GLNc | 312.86 (89.18) | 267.42 (86.9) | 298.59 (123.41) | 0.20 |
| ALAc | 288.47 (97.03) | 271.77 (119.82) | 290.52 (133.26) | 0.80 |
| TRPc | 32.97 (13.15) | 35.4 (18.89) | 36.08 (19.94) | 0.76 |
| ILEc | 55.38 (18.94) | 84.28 (34.53) | 52.01 (20.91) | <.001 Ϯ, b |
| LYSc | 175.44 (58.35) | 134.59 (65.11) | 164.38 (85.24) | 0.07 |
aComparison GDM and NG, bcomparison T2D and NG, ϮComparison GDM and T2D
cData presented as mean (SD)
Data presented as median (IQR)
According to Kruskal Walis
Boldface indicates significance of data with p_value <0.05